Is anyone still following this one? I'm pretty new to valuation and I know biotechs are tricky anyway, but would anyone like to take a crack at it? The price has gone up quite a bit in the last few months.
ya, tell me about it, I started buying last April and have seen over 100% returns. There is potential for greater growth, but the big discount is about over. I think it is fairly valued now, FWIW.
Yeah, on yahoo finance I was reading that institutions have control over virtually all the float... so it probably isn't a "hidden gem" candidate any more. I'll be watching closely, and hopefully getting more practice at valuation in the meantime. Thanks for the reply.
I concur that ILMN is fully valued at this point (as compared to, say, AFFX, which is a competitor and has dropped quite a bit recently). Still seems to be a quality outfit worth tracking, though.Rumor on another board has it that there is legal action between those two. Any knowledge?jp
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |